Performance qualification of a new hypromellose capsule: Part II. Disintegration and dissolution comparison between two types of hypromellose capsules

International Journal of Pharmaceutics

Volumn 416, Issue 1, 2011, Pages 16-24

  Ku, M Sherry ^a   Lu, Qinghong ^a   Li, Weiyi ^b   Chen, Yansong ^a  

^a WYETH RESEARCH   (United States)

^b ALLERGAN INC   (United States)

Author keywords

Disintegration; Dissolution; Hypromellose capsules; Rupture time

Indexed keywords

CARRAGEENAN; HYDROXYPROPYLMETHYLCELLULOSE; IRON OXIDE; POTASSIUM ION; TITANIUM DIOXIDE; WATER;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG CAPSULE; DRUG FORMULATION; DRUG SOLUBILITY; GELATION; IN VIVO STUDY; PRIORITY JOURNAL;

BUFFERS; CAPSULES; CARRAGEENAN; DRUG COMPOUNDING; EXCIPIENTS; HYDROGEN-ION CONCENTRATION; METHYLCELLULOSE; SOLUBILITY;

EID: 80051794238     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.02.048     Document Type: Article

References (37)

1. D.A. Alderman A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms Int. J. Pharm. Technol. Prod. Manufac. 5 1984 1 9 (Pubitemid 15105124)
2. Benameur, H.; 2010. Private communication. Capsugel. Feb.
3. M.C. Bonferoni, S. Rossi, F. Ferrari, and C. Caramella Development of oral controlled-release tablet formulations based on diltiazem-carrageenan complex Pharm. Dev. Tech. 9 2004 155 162 (Pubitemid 38788642)
4. M.C. Bonferoni, S. Rossi, F. Ferrari, M. Bertoni, G.K. Boluis, and C. Caramella On the employment of κ-carrageenan-HPMC hydrophilic matrix. III. Optimization of a lambda carrageenan-HPMC hydrophilic matrix J. Control. Release 51 1998 231 239 (Pubitemid 28252875)
5. M.C. Bonferoni, S. Rossi, F. Ferrari, G.P. Bettinetti, and C. Caramella Characterization of a diltiazem-lamda carrageenan complex Int. J. Pharm. 200 2000 207 216
6. M.C. Bonferoni, S. Rossi, M. Tamayo, J.L. Pedraz, A. Dominguez-Gil, and C. Caramella On the employment of κ-carrageenan and hydroxypropylmethylcellulose mixtures. II. Lamda-carrageenan and hydroxypropylmethylcellulose mixtures J. Control. Release 30 1994 175 182 (Pubitemid 24215436)
7. J. Brown, N. Madit, E.T. Cole, I.R. Wilding, and D. Cade Effect of cross-linking on the in vivo disintegration of hard gelatin capsules Pharm. Res. 15 1998 1026 1030 (Pubitemid 28356918)
8. Cade, D.; He, X.; Scott, R.A.; 2001. Polymer film composition for capsules. European Patent No. 0946637B1.
9. I. Chiwele, B.E. Jones, and F. Podczeck The shell dissolution of various empty hard capsules Chem. Pharm. Bull. 48 2000 951 956 (Pubitemid 30485389)
10. E.T. Cole, R.A. Scott, D. Cade, A.L. Connor, and I. Wilding In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules Pharm. Res. 21 2004 793 798 (Pubitemid 39011302)
11. S.K. Cole, M.J. Story, D. Attwood, T. Laudanski, J. Robertson, and S.G. Barnwell Studies using a non-ionic surfactant-containing drug delivery system designed for hard gelatin capsule compatibility Int. J. Pharm. 88 1992 211 220 (Pubitemid 23000423)
12. 2+ cations on gelation of κ-carrageenan G.O. Phillips, P.A. Williams, Gums and Stabilisers for the Food Industry vol. 11 2002 Royal Society of Chemistry Cambridge, UK 158 164
13. J.B. Dressman, G.L. Amidon, C. Reppas, and V.P. Shah Dissolution testing as prognostic tool for oral drug absorption: immediate release dosage forms Pharm. Res. 15 1998 11 22 (Pubitemid 28080861)
14. Y. El-Malah, and S. Nazzal Hard gelatin and hypromellose (HPMC) capsules: estimation of rupture time by real-time dissolution spectroscopy Drug Dev. Ind. Pharm. 33 2007 27 34 (Pubitemid 46034147)
15. M. Hariharan, T.A. Wheatley, and J.C. Price Controlled-release tablet matrices from carrageenans: compression and dissolution studies Pharm. Dev. Tech. 2 1997 383 393 (Pubitemid 28249303)
16. O. Honkanen, H. Seppä, S. Eerikäinen, R. Tuominen, and M. Marvola Bioavailability of ibuprofen from orally and rectally administered hydroxypropyl methyl cellulose capsules compared to corresponding gelatin capsules STP Pharma Sci. 11 2001 181 185 (Pubitemid 32274926)
17. N. Kavanagh, and O.I. Corrigan Swelling and erosion properties of hydroxypropylmethylcellulose (hypromellose) matrices - influence of agitation rate and dissolution medium composition Int. J. Pharm. 279 2004 141 152 (Pubitemid 38968649)
18. ® and gelatin capsules Int. J. Pharm. 386 2010 30 41
19. S.M. Liebowitz, W.A. Vadino, and T.J. Ambrosio Determination of hard gelatin capsule brittleness using a motorized compression test stand Drug Dev. Ind. Pharm. 16 1990 995 1010 (Pubitemid 20147818)
20. Matsuura, S.; Tanjoh, M.; 2003. Hard capsule formed of cellulose ether film with a specific content of methoxyl and hydroxypropoxyl groups. US Patent No. 6,649,180B1, November.
21. S. Missaghi, and R. Fassihi Evaluation and comparison of physicomechanical characteristics of gelatin and hypromellose capsules Drug Dev. Ind. Pharm. 32 2006 829 838 (Pubitemid 44266767)
22. K. Mitchell, J.L. Ford, D.J. Armstrong, P.N.C. Elliott, C. Rostron, and J.E. Hogan The influence of additives on the cloud point, disintegration and dissolution of hydroxypropylmethylcellulose gels and matrix tablets Int. J. Pharm. 66 1990 233 242
23. J. Nerukar, H.W. Jun, J.C. Price, and M.O. Park Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates Eur. J. Pharm. Biopharm. 61 2005 56 68 (Pubitemid 41096689)
24. T. Ogura, F. Yoshihiro, and S. Matsuura HPMC capsules - an alternative to gelatin Pharm. Tech. Eur. 10 1998 32 42 (Pubitemid 28506170)
25. K.M. Picker Matrix tablets of carrageenans. II. Release behavior and effect of added cations Drug Dev. Ind. Pharm. 25 1999 339 346 (Pubitemid 29108681)
26. K.M. Picker The use of carrageenan in mixture with microcrystalline cellulose and its functionality for making tablets Eur. J. Pharm. Biopharm. 48 1999 27 36 (Pubitemid 29308922)
27. L. Piculell Gelling carrageenan A.M. Stephen, Food Polysaccharides and their Applications 1995 Marcel Dekker New York 205 244
28. F. Podczeck, and B.E. Jones The in vitro dissolution of theophylline from different types of hard shell capsules Drug Dev. Ind. Pharm. 28 2002 1163 1169 (Pubitemid 35278840)
29. ® capsules during dissolution? Qualicaps Group, July 2009.
30. R.C. Rowe, P.S. Shskey, and P.J. Weller Handbook of Pharmaceutical Excipients 5th ed. 2003 Pharmaceutical Press/American Pharmacists Association London, UK/Washington, DC, USA
31. G.R. Sanderson, and R.C. Clark Gellan Gum, a new gelling polysaccharide G.O. Phillips, D.J. Wedlock, P.A. Williams, Gums and Stabilisers for the Food Industry vol. 2 1984 Pergamon Press Oxford 201 210
32. G.H. Therkelsen Carrageenan R.L. Whistler, J.N. BeMiller, Industrial Gums, Polysaccharides and their Derivatives 1993 Academic Press New York 145 180
33. S. Tochio, S. Nagata, and S. Yamashita The influence of the composition of test fluids on dissolution from HPMC capsules AAPS PharmSci. 4 2002 (abstract W4340)
34. C. Tuleu, M.K. Khela, D.F. Evans, B.E. Jones, S. Nagata, and A.W. Basit A scintigraphic investigation of the disintegration behaviour of capsules in fasting subjects: a comparison of hypromellose capsules containing carrageenan as a gelling agent and standard gelatin capsules Eur. J. Pharm. Sci. 30 2007 155 251
35. M. Watase, and K. Nishinari Thermal and rheological properties of kappa-carrageenan gels containing alkali earth metal ions G.O. Phillips, D.J. Wedlock, P.A. Williams, Gums and Stabilisers for the Food Industry vol. 3 1986 Elsevier London 185 194
36. Yamamoto, T.; Abe, K.; Matsuura, S.; 1993. Hard capsule for pharmaceutical drugs and method for producing the same. US Patent No. 5,264,223, November.
37. Yamamoto, T.; Matsuura, S.; Akai, K.; 1998. Capsule shell. US Patent No. 5,756,123, 26 May.